|
|
- 2018
合并第二原发癌的乳腺癌患者的病理特征及预后
|
Abstract:
摘要 目的： 分析患第二原发癌的乳腺癌患者的临床病理特征及预后因素.方法: 将19例患第二原发癌的乳腺癌患者作为试验组,选取同期19列单纯乳腺癌患者作为对照组,对比两组患者年龄、TNM分期、增殖细胞相关核抗原(Ki-67)、雌激素受体(ER)、孕激素受体(PR)、表皮生长因子受体-2(HER-2)表达及生存率间的差异.结果: 实验组中6例 (31.58%)再发妇科系统恶性肿瘤.实验组与对照组比较诊断年龄更大(P=0.02),实验组比对照组乳腺癌TNM分期更晚(P=0.008).对照组比实验组的存活率更高(P=0.017).结论: 老年乳腺癌患者更易再发恶性肿瘤,第二原发癌患者的原发乳腺癌的TNM分期较高.患第二原发癌的患者比单纯乳腺癌患者预后差,多原发肿瘤患者的预后取决于第二原发肿瘤的类型.
| [1] | FERLAY J, SOERJOMATARAM I, DIKSHIT R, et al.Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012[J]. International Journal of Cancer, 2015, 136(5):E359-E386. |
| [2] | SHIN D W, CHO B, KIM S Y, et al.Management of cancer survivors in clinical and public health perspectives:currentstatus and future challenges in Korea[J]. J Korean Med Sci, 2013,28(5):651-657. |
| [3] | KIROVA Y, DE-RYCKE Y, GAMBOTTI L, et al.Second malignancies after breast cancer: the impact of different treatment modalities[J]. British Journal of Cancer, 2008, 98(5):870-874. |
| [4] | HOWELL S J, WARDLEY A M, ARMSTRONG A C.Re: Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer[J]. Journal of the National Cancer Institute, 2009, 101(10):736. |
| [5] | TABUCHI T, ITO Y, IOKA A, et al.Incidence of metachronous second primary cancers in Osaka, Japan: Update of analysis using population-based cancer registry data[J]. Cancer Science, 2012, 103(6):1111. |
| [6] | SCHENKER J G, LEVINSKY R, OHEL G.Multiple primary malignant neoplasms in breast cancer patients in Israel[J]. Cancer, 1984, 54(1):145. |
| [7] | RAYMOND J S, HOGUE C J R. Multiple primary tumours in women following breast cancer, 1973-2000[J]. British Journal of Cancer, 2006, 94(11):1745-1750. |
| [8] | SHIN D W, BAIK Y J, KIM Y W, et al.Knowledge, attitudes, and practice on second primary cancer screening among cancer survivors: a qualitative study[J]. Patient Education & Counseling, 2011, 85(1):74-78. |
| [9] | SHIN D W, KIM Y, BAEK Y J, et al.Oncologists experience with second primary cancer screening: current practices and barriers and potential solutions.[J]. Asian Pacific Journal of Cancer Prevention Apjcp, 2012, 13(2):671. |
| [10] | WOOSTER R, STRATTON M R.Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13[J]. Science, 1994, 265(5181):2088. |
| [11] | CUZICK J, POWLES T, VERONESI U, et al.Overview of the main outcomes in breast-cancer prevention trials[J]. Lancet, 2003, 361(9354):296. |
| [12] | KIROVA Y M, RYCKE Y D, GAMBOTTI L, et al.Second malignancies after breast cancer: the impact of different treatment modalities[J]. British Journal of Cancer, 2008, 98(5):870-874. |
| [13] | 张清, 张琴琴, 黄信,等. 脂肪溶解液用于乳腺癌腋窝淋巴结解剖[J]. 暨南大学学报(自然科学与医学版), 2017(5):417-421. |
| [14] | ZHANG Q, ZHANG Q Q, HUANG X,et al.Clinical study on the application of liposuction in lymph nodes anatomy after axillary dissection in breast cancer[J]. Journal of Jinan University (Natural Science & Medicine Edition), 2017(5):417-421. |
| [15] | FAN L, STRASSERWEIPPL K, LI J J, et al.Breast cancer in China[J]. Lancet Oncology, 2014, 15(7):279-289. |
| [16] | GRUNDMANN R T, MEYER F.Second primary malignancy among cancer survivors-epidemiology, prognosis and clinical relevance[J]. Zentralblatt Für Chirurgie, 2012, 137(6):565-574. |
| [17] | FERLAY J, SOERJOMATARAM I, ERVIK M, et al.GLOBOCAN 2012 v1.1, Cancer incidence and mortality worldwide: IARC cancerbase No.11[J]. International Journal of Cancer Journal International Cancer, 2014, 136(5): E359-E386. |
| [18] | TRAVIS L B, WAHNEFRIED W D, ALLAN J M, et al.Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors[J]. Nature Reviews Clinical Oncology, 2013, 10(5):289-301. |
| [19] | HAMMOND M E, HAYES D F, DOWSETT M, et al.American society of clinical oncology/college of american pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer[J]. Archives of Pathology & Laboratory Medicine, 2010, 131(1):18. |
| [20] | WOLFF A C, HAMMOND M E, HICKS D G, et al.Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: american society of clinical oncology/college of american pathologists clinical practice guideline update[J]. Journal of Clinical Oncology Official Journal of the American Society of Clinical Oncology, 2013, 31(31):3997. |
